U.S. Markets closed

Beyond Air, Inc. (XAIR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.75+0.06 (+1.05%)
At close: 04:00PM EDT
5.75 0.00 (0.00%)
After hours: 07:52PM EDT

Beyond Air, Inc.

825 East Gate Boulevard
Suite 320
Garden City, NY 11530
United States
516 665 8200

IndustryMedical Devices
Full Time Employees41

Key Executives

NameTitlePayExercisedYear Born
Mr. Steven Adam LisiCEO & Chairman450kN/A1971
Mr. Amir AvnielCo-Founder, Pres, COO & Director400kN/A1974
Mr. Douglas Quinton LarsonCFO, Principal Financial Officer & Principal Accounting OfficerN/AN/A1971
Ms. Maria YonkoskiHead of Investor RelationsN/AN/AN/A
Mr. Adam NewmanChief Legal Officer & Gen. CounselN/AN/AN/A
Ms. Rebecca Van DorenHead of SalesN/AN/AN/A
Ms. Kori-Ann TaylorHead of MarketingN/AN/AN/A
Prof. Andrew R. Colin M.D.Chief Medical Officer & Member of Scientific Advisory BoardN/AN/AN/A
Dr. Giora Davidai M.D.Chief Medical OfficerN/AN/AN/A
Mr. Duncan FatkinChief Commercial OfficerN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) generator and delivery systems. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of persistent pulmonary hypertension of the newborn; acute viral pneumonia, including COVID-19; bronchiolitis and nontuberculous mycobacteria lung infections; and solid tumors. It operates in Israel, Ireland, Australia, and the European Union. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

Corporate Governance

Beyond Air, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.